Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acquired Immunodeficiency Syndrome × Tumor Necrosis Factor-alpha × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Dermatologic 1

Conditions

Melanoma 3 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma, Kaposi 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1

Interventions

tin etiopurpurin 1 Tumor Necrosis Factor-alpha 1 Semaxinib 1 Ritonavir 1 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002262 2005-06-24

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase 1 Completed

DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡